Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | El-Gamal, Mohammed I. | - |
dc.contributor.author | Khan, Mohammad Ashrafuddin | - |
dc.contributor.author | Abdel-Maksoud, Mohammed S. | - |
dc.contributor.author | El-Din, Mahmoud M. Gamal | - |
dc.contributor.author | Oh, Chang-Hyun | - |
dc.date.accessioned | 2024-01-20T08:31:10Z | - |
dc.date.available | 2024-01-20T08:31:10Z | - |
dc.date.created | 2022-01-10 | - |
dc.date.issued | 2014-11-24 | - |
dc.identifier.issn | 0223-5234 | - |
dc.identifier.uri | https://pubs.kist.re.kr/handle/201004/126099 | - |
dc.description.abstract | Synthesis of a new series of diarylamides possessing 6,7-dimethoxy(dihydroxy)quinoline scaffold is described. Their in vitro antiproliferative activities against NCI-58 human cancer cell lines of nine different cancer types were tested. Compounds 1a and 1d-g showed the highest mean %inhibition values oyer the 58 cell line panel at 10 mu M, and they were further tested in 5-dose testing mode to determine their IC50 values. The five compounds were more potent than Imatinib against all the cell lines of nine different cancer types. Compound 1g showed the highest potencies. It showed inhibitory effect against C-RAF kinase (76.65% at 10 mu M concentration). (C) 2014 Elsevier Masson SAS. All rights reserved. | - |
dc.language | English | - |
dc.publisher | ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER | - |
dc.subject | MELANOMA-CELL LINE | - |
dc.subject | PRELIMINARY CYTOTOXICITY EVALUATION | - |
dc.subject | ANTIPROLIFERATIVE ACTIVITY | - |
dc.subject | 1,3,4-TRIARYLPYRAZOLE SCAFFOLD | - |
dc.subject | BIOLOGICAL EVALUATION | - |
dc.subject | POTENTIAL ANTITUMOR | - |
dc.subject | LUNG CANCERS | - |
dc.subject | C-RAF | - |
dc.subject | DERIVATIVES | - |
dc.subject | DESIGN | - |
dc.title | A new series of diarylamides possessing quinoline nucleus: Synthesis, in vitro anticancer activities, and kinase inhibitory effect | - |
dc.type | Article | - |
dc.identifier.doi | 10.1016/j.ejmech.2014.09.068 | - |
dc.description.journalClass | 1 | - |
dc.identifier.bibliographicCitation | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, v.87, pp.484 - 492 | - |
dc.citation.title | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY | - |
dc.citation.volume | 87 | - |
dc.citation.startPage | 484 | - |
dc.citation.endPage | 492 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.identifier.wosid | 000363431300045 | - |
dc.identifier.scopusid | 2-s2.0-84949116139 | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.type.docType | Article | - |
dc.subject.keywordPlus | MELANOMA-CELL LINE | - |
dc.subject.keywordPlus | PRELIMINARY CYTOTOXICITY EVALUATION | - |
dc.subject.keywordPlus | ANTIPROLIFERATIVE ACTIVITY | - |
dc.subject.keywordPlus | 1,3,4-TRIARYLPYRAZOLE SCAFFOLD | - |
dc.subject.keywordPlus | BIOLOGICAL EVALUATION | - |
dc.subject.keywordPlus | POTENTIAL ANTITUMOR | - |
dc.subject.keywordPlus | LUNG CANCERS | - |
dc.subject.keywordPlus | C-RAF | - |
dc.subject.keywordPlus | DERIVATIVES | - |
dc.subject.keywordPlus | DESIGN | - |
dc.subject.keywordAuthor | Antiproliferative activity | - |
dc.subject.keywordAuthor | Diarylamide | - |
dc.subject.keywordAuthor | In silico | - |
dc.subject.keywordAuthor | C-RAF kinase | - |
dc.subject.keywordAuthor | Quinoline | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.